Literature DB >> 16042687

Serological identification of adult T-cell leukaemia-associated antigens.

Masakatsu Hishizawa1, Kazunori Imada, Tomomi Sakai, Maki Ueda, Toshiyuki Hori, Takashi Uchiyama.   

Abstract

Adult T-cell leukaemia (ATL) is a peripheral T-cell neoplasm caused by human T-cell leukaemia virus type I (HTLV-I). Several clinical observations suggest that some tumour-associated antigens in ATL may be recognised by the immune system. In this study, we performed the serological screening of an expression library to identify ATL-associated antigens by using materials from a unique ATL patient with long-term stable disease. Among five distinct genes isolated, serine/arginine protein kinase 1 (SRPK1), which has been reported to have a restricted normal tissue distribution, was found to be overexpressed in most acute type ATL samples, but not in chronic type ATL or in normal peripheral blood mononuclear cells by real-time reverse transcription polymerase chain reaction. Interestingly, the overexpression of SRPK1 in aggressive types of ATL was more exclusively observed at the protein level than at the mRNA level. Autologous antibody to SRPK1 was confirmed in the ATL patient using Western blot analysis with plasma, but not detected in asymptomatic HTLV-I carriers or in healthy volunteers. These results indicate that SRPK1 may be useful for the development of therapeutic and diagnostic methods for patients with ATL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16042687     DOI: 10.1111/j.1365-2141.2005.05619.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus.

Authors:  Zhihong Zhou; Jinsong Qiu; Wen Liu; Yu Zhou; Ryan M Plocinik; Hairi Li; Qidong Hu; Gourisanker Ghosh; Joseph A Adams; Michael G Rosenfeld; Xiang-Dong Fu
Journal:  Mol Cell       Date:  2012-06-21       Impact factor: 17.970

2.  Antibody responses associated with the graft-versus-leukemia effect in adult T-cell leukemia.

Authors:  Masakatsu Hishizawa; Kazunori Imada; Tomomi Sakai; Momoko Nishikori; Nobuyoshi Arima; Mitsuru Tsudo; Takayuki Ishikawa; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

3.  Expression of SRPK1 in gliomas and its role in glioma cell lines viability.

Authors:  Ioanna Sigala; Konstantinos I Tsamis; Anna Gousia; George Alexiou; Spyridon Voulgaris; Thomas Giannakouros; Athanassios P Kyritsis; Eleni Nikolakaki
Journal:  Tumour Biol       Date:  2016-01-06

4.  Elevated expression of the serine-arginine protein kinase 1 gene in ovarian cancer and its role in Cisplatin cytotoxicity in vitro.

Authors:  Kunle Odunsi; Paulette Mhawech-Fauceglia; Christopher Andrews; Amy Beck; Olajumoke Amuwo; Shashikant Lele; Jennifer D Black; Ruea-Yea Huang
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

5.  Protein-Protein Interaction Inhibitor of SRPKs Alters the Splicing Isoforms of VEGF and Inhibits Angiogenesis.

Authors:  Qingyun Li; Chuyue Zeng; Haizhen Liu; Kristen Wing Yu Yung; Chun Chen; Qiuling Xie; Yu Zhang; Stephanie Winn Chee Wan; Bertha Sze Wing Mak; Jiang Xia; Sheng Xiong; Jacky Chi Ki Ngo
Journal:  iScience       Date:  2021-04-20

6.  Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340).

Authors:  Raoni Pais Siqueira; Éverton de Almeida Alves Barbosa; Marcelo Depólo Polêto; Germanna Lima Righetto; Thiago Vargas Seraphim; Rafael Locatelli Salgado; Joana Gasperazzo Ferreira; Marcus Vinícius de Andrade Barros; Leandro Licursi de Oliveira; Angelo Brunelli Albertoni Laranjeira; Márcia Rogéria Almeida; Abelardo Silva Júnior; Juliana Lopes Rangel Fietto; Jörg Kobarg; Eduardo Basílio de Oliveira; Robson Ricardo Teixeira; Júlio César Borges; Jose Andrés Yunes; Gustavo Costa Bressan
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

Review 7.  Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives.

Authors:  Ilias P Nikas; Sophie C Themistocleous; Stavroula A Paschou; Konstantinos I Tsamis; Han Suk Ryu
Journal:  Cells       Date:  2019-12-19       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.